Sort by

Send to

Choose Destination

Search results

Items: 5


Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer.

Magani F, Bray ER, Martinez MJ, Zhao N, Copello VA, Heidman L, Peacock SO, Wiley DJ, D'Urso G, Burnstein KL.

Mol Syst Biol. 2018 Aug 14;14(8):e8202. doi: 10.15252/msb.20188202.


Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.

Magani F, Peacock SO, Rice MA, Martinez MJ, Greene AM, Magani PS, Lyles R, Weitz JR, Burnstein KL.

Mol Cancer Res. 2017 Nov;15(11):1469-1480. doi: 10.1158/1541-7786.MCR-17-0280. Epub 2017 Aug 15.


Predation risk modifies behaviour by shaping the response of identified brain neurons.

Magani F, Luppi T, Nuñez J, Tomsic D.

J Exp Biol. 2016 Apr 15;219(Pt 8):1172-7. doi: 10.1242/jeb.136903.


The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.

Rice MA, Ishteiwy RA, Magani F, Udayakumar T, Reiner T, Yates TJ, Miller P, Perez-Stable C, Rai P, Verdun R, Dykxhoorn DM, Burnstein KL.

Oncogene. 2016 Sep 8;35(36):4752-61. doi: 10.1038/onc.2016.6. Epub 2016 Feb 22.


Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy.

Arbustini E, Diegoli M, Morbini P, Dal Bello B, Banchieri N, Pilotto A, Magani F, Grasso M, Narula J, Gavazzi A, Viganò M, Tavazzi L.

J Am Coll Cardiol. 2000 Jun;35(7):1760-8. Review.

Supplemental Content

Loading ...
Support Center